<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="364245">
  <stage>Registered</stage>
  <submitdate>14/05/2013</submitdate>
  <approvaldate>3/06/2013</approvaldate>
  <actrnumber>ACTRN12613000629730</actrnumber>
  <trial_identification>
    <studytitle>A prospective, multi-centre randomised comparative study of
implant fit, clinical outcomes and satisfaction with the Stryker Accolade II Hip Stem compared to the Corail Hip Stem</studytitle>
    <scientifictitle>A prospective, multi-centre randomised comparative study of
implant fit, clinical outcomes and satisfaction with the Stryker Accolade II Hip Stem compared to the Corail Hip Stem</scientifictitle>
    <utrn>U1111-1143-0732 </utrn>
    <trialacronym>Accolade II-12</trialacronym>
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Total Hip Replacement Surgery</healthcondition>
    <healthcondition>Non-Inflammatory Degenerative Joint Disease of the Hip</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Other muscular and skeletal disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patients randomised to this group will recieve an Accolade II Hip Stem. Duration of surgery is approximately 1.5hours. </interventions>
    <comparator>Patients randomised to this group will recieve a Depuy Corail Hip Stem. Duration of surgery is approximately 1.5hours.A second comparator the Anato hip stem will be investigated in the NZ substudy. Patients randomised to this group will receive an Anato hip stem. Duration of surgery is approximately 1.5 hours.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Surgery</interventioncode>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>1. To compare the pre-operative plan with the intraoperative size preferance of femoral stem in patients randomised to either Accolade II or Corail femoral stem.  
Radiolographs and surgical data</outcome>
      <timepoint>Pre-Operative, Intra-Operative, Post - Operative - 6 weeks
6 months, 12 months, 24 months</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>2. To determine clinical outcomes of THR, using the Oxford Hip Score, in patients receiving the Accolade II femoral stem compared to Corail femoral stem
</outcome>
      <timepoint>Pre-Operative, Post - Operative - 6 weeks
6 months, 12 months, 24 months</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>NZ iDXA/Anato stem substudy primary outcome: To compare the % differences in pre-operative (BMD) over time, in the regions of interest (ROIs) based on the Gruen zones, around the Accolade II, Corail or Anato stems. This percent change in BMD will be measured using an iDXA machine.</outcome>
      <timepoint>Pre-op, 6 week, 12 mnth, 24 mth</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>1. To determine the femoral canal fit of Accolade II femoral stem compared to the Corail femoral stem, looking at metaphseal, diaphyseal or combined engagement of the stem during the first two years postoperatively.
Radiographs </outcome>
      <timepoint>Pre-Operative, Post - Operative - 6 weeks
6 months, 12 months, 24 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>2. To further determine clinical outcomes of THR (including pain, function and health related quality of life) with
Accolade II femoral stem compared to Corail femoral stem via: EQ5D a standardised instrument for use as a measure of health outcome, and VAS Pain scale.
</outcome>
      <timepoint>Pre-Operative, Post - Operative - 6 weeks
6 months, 12 months, 24 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>3. To determine patient satisfaction with THR experience and compare satisfaction with Accolade II femoral stem, v.Corail femoral stem. Likert scale</outcome>
      <timepoint>Post - Operative - 6 weeks, 6 months, 12 months, 24 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>4. To determine surgeon satisfaction with use of the Accolade II femoral stem compared to use of the Corail femoral stem. Likert Scale</outcome>
      <timepoint>Intra-Operative, Post - Operative - 6 weeks
6 months, 12 months, 24 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>5. To compare incidence of loosening, thigh pain, reoperation and revision in patients receiving Accolade II femoral stem compared to Corail femoral stem. 
Medical/Surgical Data, Radiography.</outcome>
      <timepoint>Intra-Operative, Post - Operative - 6 weeks
6 months, 12 months, 24 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>6. To determine length of hospital stay in patient receiving Accolade II femoral stem, compared to Corail femoral stem. </outcome>
      <timepoint>Intra-Operative</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>In a subgroup: to determine if serum metal ion levels are increased following implant with Accolade II femoral stem compared to Corail femoral stem.
Pathology</outcome>
      <timepoint>Pre-operative, 6 months, 12 months, 24 months post-operatively</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>(NZ iDXA/Anato stem substudy ONLY): HAAS High activity arthroplasty score</outcome>
      <timepoint>Pre-Op, 6 week, 6 mth, 12mth, 24 mth</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1.Patient are male or non-pregnant females requiring a cementless THR for non-inflammatory degenerative joint disease of the hip.
2.Must be older than 18 years 
</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. Patient has a cognitive impairment, an intellectual disability or a mental illness 
2. People whose primary language is other than English 
3. Pregnant Women
4. Children and or/young people (ie. &lt;18 years) 
</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1>True</masking1>
    <masking2>False</masking2>
    <masking3>False</masking3>
    <masking4>False</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>4/06/2013</anticipatedstartdate>
    <actualstartdate>13/08/2013</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>250</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia,Outside</recruitmentcountry>
    <recruitmentstate>QLD,WA,VIC</recruitmentstate>
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state>Cantebury</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Stryker Australia Pty Ltd</primarysponsorname>
    <primarysponsoraddress>8 Herbert Street
St Leonards
NSW 2065</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Stryker Australia Pty Ltd</fundingname>
      <fundingaddress>8 Herbert Street
St Leonards
NSW 2065</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study is a prospective, multi-centre, randomised clinical study comparing the preoperative radiographic plan to the intra-operative femoral stem sizing, and assessing post-operative fit, clinical and satisfaction outcomes. The study will be conducted in patients with Non-inflammatory Degenerative Joint Disease. In addition, a substudy is running in NZ to evaluate the differences in peri-prosthetic bone remodelling post hip replacement in 3 different femoral component implants.  The Lunar iDXA (GE Healthcare, Madison, WI) densitometer is a Food and Drug Administration (FDA) - approved device for measuring BMD and body composition. The relationship between bone loss, patient functional outcome and implant survival across the 3 femoral stems will also be investigated. </summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Southern Health Ethics</ethicname>
      <ethicaddress>Monash Medical Centre
246 Clayton Road 
Clayton Victoria 3168</ethicaddress>
      <ethicapprovaldate>20/02/2013</ethicapprovaldate>
      <hrec>HREC/12/SHB/19</hrec>
      <ethicsubmitdate>23/11/2012</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Monash Health</ethicname>
      <ethicaddress>Monash Health
Monash Medical Centre 
246 Clayton Road 
Clayton Victoria 3168
</ethicaddress>
      <ethicapprovaldate>23/01/2015</ethicapprovaldate>
      <hrec>HREC/12/SHB/19</hrec>
      <ethicsubmitdate>11/11/2014</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>South Metropolitan Health Service</ethicname>
      <ethicaddress>Research Ethics and Governance Unit
South Metropolitan Health Service
Level 3 Perkins South Building, 
Fiona Stanley Hospital Campus
Locked Bag 100, PALMYRA DC WA 6961</ethicaddress>
      <ethicapprovaldate>14/03/2013</ethicapprovaldate>
      <hrec>13/2</hrec>
      <ethicsubmitdate>11/12/2012</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Southern Health and Disability Ethics Committee</ethicname>
      <ethicaddress>C/- Medsafe, level 6, Deloitte House
10 Brandon Street
PO Box 5013 
Wellington </ethicaddress>
      <ethicapprovaldate>6/03/2014</ethicapprovaldate>
      <hrec>12/STH/56/AM02</hrec>
      <ethicsubmitdate>25/02/2014</ethicsubmitdate>
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Ton Tran</name>
      <address>Dandenong Hospital
David Street 
Dandenong VIC 3175</address>
      <phone>+61 3 9554 8945</phone>
      <fax />
      <email>Ton.Tran@monashhealth.org</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Mrs</title>
      <name>Natascha Millard</name>
      <address>Stryker 
8 Herbert Street
St Leonards
NSW 2065</address>
      <phone>+61 2 9467 1073</phone>
      <fax />
      <email>Natascha.Millard@stryker.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Mrs</title>
      <name>Natascha Millard</name>
      <address>Stryker
8 Herbert Street
St Leonards
NSW 2065</address>
      <phone>+61 2 9467 1073</phone>
      <fax />
      <email>Natascha.Millard@stryker.com</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Mrs</title>
      <name>Alissa Connelly</name>
      <address>8 Herbert St, St Leonards NSW 2065</address>
      <phone>+61294671075</phone>
      <fax />
      <email>alissa.connelly@stryker.com</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>